Home > Pregabalin harm reduction campaign launched on drugs.ie.

[drugs.ie] Pregabalin harm reduction campaign launched on drugs.ie. (22 Mar 2017)

External website: http://www.drugs.ie/news/article/pregabalin_harm_r...

The Ana Liffey Drug Project, through its Online & Digital Services team, have worked in partnership with the HSE to launch a pregabalin harm reduction campaign on the drugs.ie website.

The campaign includes a webpage, fact sheet, and poster.

Pregabalin is a prescription drug used to manage several long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines, the anxiolytic (relaxing) effects of pregabalin occur rapidly after administration.

Internationally, pregabalin misuse has been reported among individuals attending addiction services and recreational drug users.

You can view the webpage and download the fact sheet and poster for your service at:

Repository Staff Only: item control page